Ovid Therapeutics Inc. (OVID)
NASDAQ: OVID · Real-Time Price · USD
2.700
+0.010 (0.37%)
Apr 28, 2026, 4:00 PM EDT - Market closed
Ovid Therapeutics Employees
Ovid Therapeutics had 23 employees as of December 31, 2025. The number of employees did not change compared to the previous year.
Employees
23
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
$315,304
Profits / Employee
-$745,304
Market Cap
467.20M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Valneva SE | 674 |
| Ginkgo Bioworks Holdings | 485 |
| REGENXBIO | 371 |
| Entrada Therapeutics | 152 |
| Aura Biosciences | 113 |
| Prelude Therapeutics | 79 |
| Assembly Biosciences | 73 |
| Larimar Therapeutics | 71 |
OVID News
- 14 days ago - Ovid Therapeutics Transcript: Status update - Transcripts
- 20 days ago - Ovid Therapeutics to Host Potassium-Chloride Co-transporter 2 (KCC2) Deep Dive R&D Event on Tuesday, April 14 - GlobeNewsWire
- 5 weeks ago - Ovid Therapeutics' New Epilepsy Trial Data Ignites Rally - Benzinga
- 5 weeks ago - Ovid Therapeutics Earnings Call Transcript: Q4 2025 - Transcripts
- 5 weeks ago - Ovid Therapeutics Announces New OV329 Data and Indication Expansion, Phase 1 Clearance for OV4071, and Reports Fourth Quarter and Full Year 2025 Financial Results - GlobeNewsWire
- 5 weeks ago - Ovid Therapeutics Announces Pricing of $60 Million Private Placement - GlobeNewsWire
- 6 weeks ago - Ovid Therapeutics Transcript: Leerink Global Healthcare Conference 2026 - Transcripts
- 7 weeks ago - Ovid Therapeutics Transcript: TD Cowen 46th Annual Health Care Conference - Transcripts